...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Cytokine storm hypothesis takes a hit with the latest IL-6 targeted therapies

Whoops!!!

Looks like tocilizumab - IL6 targeting drug just took a body blow 

"Remember that French Tocilizumab trial that claimed success?

Its Data Monitoring Safety Board resigned today due to “strong disagreement”on the communication of prelim data and trial conduct"

https://twitter.com/AndyBiotech/status/1258131015790481409

 

Share
New Message
Please login to post a reply